Edwards Lifesciences News Breakdown

EW -- USA Stock  

USD 149.29  0.09  0.06%

Macroaxis does not monitor all media channels or aggregates social signals for Edwards Lifesciences. But even though we do not provide professional-grade financial sentiment analysis on Edwards Lifesciences, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Edwards Lifesciences. Additionally see Edwards Lifesciences Hype Analysis, Edwards Lifesciences Correlation and Edwards Lifesciences Performance.
  
a day ago at www.macroaxis.com         
Exercise or conversion by Michael Mussallem of 35000 shares of Edwards Lifesciences subject to Rule ...
Macroaxis News
Filed transaction by Edwards Lifesciences Corp director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
2 days ago at www.macroaxis.com         
Exercise or conversion by Larry Wood of 6300 shares of Edwards Lifesciences subject to Rule 16b-3
Macroaxis News
Filed transaction by Edwards Lifesciences Corp officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
few days ago at hillaryhq.com         
Twin Tree Management LP Upped Edwards Lifesciences Holding Spectrum Management Group Lifted Its VF ....
news
Hillary HQ BofAMerrill Lynch Upgrades VF Corp. to Buy on Vans Momentum StreetInsider.com Get full coverage
  
  
few days ago at www.macroaxis.com         
Acquisition by Michael Mussallem of 166400 shares of Edwards Lifesciences subject to Rule 16b-3
Macroaxis News
Filed transaction by Edwards Lifesciences Corp director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
  
  
few days ago at www.macroaxis.com         
Edwards Lifesciences exotic insider transaction detected
Macroaxis News
Filed transaction by Edwards Lifesciences Corp officer. Unconventional Insider trading
  
  
six days ago at www.macroaxis.com         
Sale by Kehl John H Jr of 100 shares of Edwards Lifesciences
Macroaxis News
Filed transaction by Edwards Lifesciences Corp officer. General open market or private sale of non-derivative or derivative security
  
  
over a week ago at www.macroaxis.com         
Payment of 282 shares by Scott Ullem of Edwards Lifesciences subject to Rule 16b-3
Macroaxis News
Filed transaction by Edwards Lifesciences Corp officer. Payment of exercise price or tax liability by delivering or withholding securities
  
  
over a week ago at www.macroaxis.com         
Acquisition by Stone Heisz Leslie of 1913 shares of Edwards Lifesciences subject to Rule 16b-3
Macroaxis News
Filed transaction by Edwards Lifesciences Corp director. Grant, award or other acquisition pursuant to Rule 16b-3
  
  
over a week ago at www.macroaxis.com         
Sale by Garren Bruce P of 100 shares of Edwards Lifesciences
Macroaxis News
Filed transaction by Edwards Lifesciences Corp officer. General open market or private sale of non-derivative or derivative security
  
  
over a week ago at www.macroaxis.com         
Exercise or conversion by Scott Ullem of 25000 shares of Edwards Lifesciences subject to Rule 16b-3
Macroaxis News
Filed transaction by Edwards Lifesciences Corp officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over a week ago at www.macroaxis.com         
Exercise or conversion by Bowlin Michael R of 4590 shares of Edwards Lifesciences subject to Rule 16...
Macroaxis News
Filed transaction by Edwards Lifesciences Corp director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over two weeks ago at www.macroaxis.com         
Sale by Scott Ullem of 4690 shares of Edwards Lifesciences
Macroaxis News
Filed transaction by Edwards Lifesciences Corp officer. General open market or private sale of non-derivative or derivative security
  
  
over two weeks ago at www.macroaxis.com         
Sale by Kehl John H Jr of 2044 shares of Edwards Lifesciences
Macroaxis News
Filed transaction by Edwards Lifesciences Corp officer. General open market or private sale of non-derivative or derivative security
  
  
over two weeks ago at www.macroaxis.com         
Exercise or conversion by Nevinny Corinne H of 10000 shares of Edwards Lifesciences subject to Rule ...
Macroaxis News
Filed transaction by Edwards Lifesciences Corp officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over two weeks ago at www.macroaxis.com         
Sale by Foster Stuart L of 200 shares of Edwards Lifesciences
Macroaxis News
Filed transaction by Edwards Lifesciences Corp officer. General open market or private sale of non-derivative or derivative security
  

Build Optimal Portfolios

Diversify Your Portfolio With Edwards Lifesciences Corporation
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Edwards Lifesciences Corporation to your portfolio

Investors are also looking into

Acquisition by Hilleman Jeryl L of 40000 shares of Minerva Neurosciences subject to Rule 16b 3
July 17, 2018 for Hilleman Jeryl L
Exercise or conversion by Jeffrey Haughton of 10000 shares of Performant Financial subject to Rule 16b 3
July 17, 2018 for Jeffrey Haughton
Acquisition by Anil Patel of 3000 shares of Franklin Financial subject to Rule 16b 3
July 17, 2018 for Anil Patel
View All Premium Stories  

Performance against DOW

 Price Growth (%)  
      Timeline 
1
Sale by Garren Bruce P of 400 shares of Edwards Lifesciences06/27/2018
2
Sale by Kehl John H Jr of 2044 shares of Edwards Lifescience...07/02/2018
3
Exercise or conversion by Scott Ullem of 25000 shares of Edw...07/06/2018
4
Payment of 282 shares by Scott Ullem of Edwards Lifesciences...07/10/2018
5
Acquisition by Michael Mussallem of 166400 shares of Edwards...07/13/2018
6
Exercise or conversion by Michael Mussallem of 35000 shares ...07/17/2018
Additionally see Edwards Lifesciences Hype Analysis, Edwards Lifesciences Correlation and Edwards Lifesciences Performance. Please also try Pair Correlation module to compare performance and examine historical correlation between any two equity instruments.